How Pharma and Medtech should respond to new EU rules on R&D on biological resources

Original languageEnglish
JournalScrip Regulatory Affairs
Pages (from-to)2-5
Number of pages4
ISSN2047-9727
Publication statusPublished - May 2016

Cite this